IL314226A - Designed cytokine compositions and methods of use - Google Patents

Designed cytokine compositions and methods of use

Info

Publication number
IL314226A
IL314226A IL314226A IL31422624A IL314226A IL 314226 A IL314226 A IL 314226A IL 314226 A IL314226 A IL 314226A IL 31422624 A IL31422624 A IL 31422624A IL 314226 A IL314226 A IL 314226A
Authority
IL
Israel
Prior art keywords
methods
cytokine compositions
designed
designed cytokine
compositions
Prior art date
Application number
IL314226A
Other languages
English (en)
Hebrew (he)
Original Assignee
Outpace Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Outpace Bio Inc filed Critical Outpace Bio Inc
Publication of IL314226A publication Critical patent/IL314226A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL314226A 2022-01-11 2023-01-11 Designed cytokine compositions and methods of use IL314226A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263298623P 2022-01-11 2022-01-11
US202363479176P 2023-01-09 2023-01-09
US202363479178P 2023-01-09 2023-01-09
US202363479177P 2023-01-09 2023-01-09
PCT/US2023/060508 WO2023137346A2 (en) 2022-01-11 2023-01-11 Designed cytokine compositions and methods of use

Publications (1)

Publication Number Publication Date
IL314226A true IL314226A (en) 2024-09-01

Family

ID=87279672

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314226A IL314226A (en) 2022-01-11 2023-01-11 Designed cytokine compositions and methods of use

Country Status (10)

Country Link
US (1) US20250223330A1 (cg-RX-API-DMAC10.html)
EP (1) EP4463469A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025502205A (cg-RX-API-DMAC10.html)
KR (1) KR20240164594A (cg-RX-API-DMAC10.html)
CN (1) CN119053616A (cg-RX-API-DMAC10.html)
AU (1) AU2023208031A1 (cg-RX-API-DMAC10.html)
CA (1) CA3248134A1 (cg-RX-API-DMAC10.html)
IL (1) IL314226A (cg-RX-API-DMAC10.html)
MX (1) MX2024008642A (cg-RX-API-DMAC10.html)
WO (1) WO2023137346A2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL325764A (en) * 2023-07-13 2026-03-01 Outpace Bio Inc Designed interleukin-2 cytokine compositions and methods for use
WO2025212606A1 (en) * 2024-04-01 2025-10-09 Bio-Techne Corporation Synthetic il-2 polypeptides and conjugates, compositions, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020025287A2 (pt) * 2018-06-25 2021-03-09 University Of Washington Projeto de novo de miméticos de interleucina potentes e seletivos
US12522640B2 (en) * 2018-07-24 2026-01-13 BioNTech SE IL2 agonists
WO2023131270A1 (en) * 2022-01-07 2023-07-13 Cure Genetics, Co., Limited Novel interleukin-2 polypeptides

Also Published As

Publication number Publication date
MX2024008642A (es) 2024-09-23
EP4463469A4 (en) 2026-01-14
KR20240164594A (ko) 2024-11-19
JP2025502205A (ja) 2025-01-24
CA3248134A1 (en) 2023-07-20
WO2023137346A3 (en) 2023-11-16
CN119053616A (zh) 2024-11-29
WO2023137346A2 (en) 2023-07-20
US20250223330A1 (en) 2025-07-10
EP4463469A2 (en) 2024-11-20
AU2023208031A1 (en) 2024-08-29

Similar Documents

Publication Publication Date Title
HUE072193T2 (hu) Antitest kompozíciók és eljárások azok felhasználásához
IL308041A (en) Collagen compositions and methods of using them
IL315862A (en) Angiotensinogen modulators and methods of using them
IL318543A (en) Protein-targeted compositions for activating fibroblasts and methods for using them
IL314922A (en) Targeted cytokines and methods of using them
EP4298076A4 (en) CERAMIC COMPOSITIONS AND METHODS OF USE
GB2622995B (en) CAS13-based compositions and methods of use thereof
IL316049A (en) Musuntuzumab pharmaceutical preparations and methods of use
IL312928A (en) Complement Factor B Modulating Preparations and Methods for Using Them
IL325628A (en) Coagulation factor xi modulators and methods of using them
IL317018A (en) Garden treatment preparations and methods of using them
IL321134A (en) Olanzapine compounds and methods of use
IL326074A (en) Fibroblast activation protein-targeting compositions and methods of using them
IL325764A (en) Designed interleukin-2 cytokine compositions and methods for use
IL311518A (en) Preparations that modulate perkalkerine and methods of using them
IL311037A (en) Lactoferrin preparations and methods of use
HK40119758A (en) Designed cytokine compositions and methods of use
IL326294A (en) Apilimod compositions and methods of use
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
IL325884A (en) Gal475 compositions and methods of use thereof
CA3297357A1 (en) Cytokine compositions and methods of use thereof
GB202511967D0 (en) Compositions and methods of using same
IL317319A (en) Antibody compounds and methods of using them
CA3288969A1 (en) Fusion cytokine compositions and methods of use thereof